According to the company, Accolade pacemakers will allow patients to receive full-body MRI scans in both 1.5 Tesla and 3.0 Tesla systems, when implanted with firm’s Ingevity leads.

Boston Scientific executive vice president and rhythm management president Joe Fitzgerald said: "We have prioritized investments and now have the first and only subcutaneous ICD, the smallest ICD, and the longest-lasting pacemaker, ICD and CRT devices in the world.

"Now, with the Accolade pacemaker family, we also offer the most flexible MRI conditional pacemaker system, along with advanced diagnostics that assist physicians in detecting atrial arrhythmias."

The company also received CE mark approval for its Visionist and Valitude CRT-Ps with quadripolar pacing technology, in addition to Accolade pacemaker family.

Both the systems provide multiple options to reach and pace the target location in the left ventricle, when paired with the Acuity X4 pacing leads.

The company noted that Accolade, Visionist, Visionist, Valitude, Origen, Ingevity, and Acuity X4 devices are not yet available for sale in the US.

Image: Boston Scientific’s Corporate Headquarters in Marlborough, Massachusetts. Photo: courtesy of Boston Scientific Corporation.